1. |
Maehle BO, Collett K, Tretli S, et al. Estrogen receptor beta-an independent prognostic marker in estrogen receptor alpha and progesterone receptorpositive breast cancer [J]. APMIS, 2009; 117(9): 644650.
|
2. |
Fox EM, Andrade J, Shupnik MA. Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways [J]. Steroids, 2009; 74(7): 622627.
|
3. |
Hopp TA, Weiss HL, Parra IS, et al. Low levels of estrogen receptor β protein predict resistance to Tamoxifen therapy in breast cancer [J]. Clin Cancer Res, 2004; 10(22): 74907499.
|
4. |
Herynk MH, Fuqua SA. Estrogen receptors in resistance to hormone therapy [J]. Adv Exp Med Biol, 2007; 608: 130143.
|
5. |
Kuiper GG, Enmark E, PeltoHuikko M, et al. Cloning of a novel receptor expressed in rat prostate and ovary [J]. Proc Natl Acad Sci, 1996; 93(12): 59255930.
|
6. |
Green CA, Peter MB, Speirs V, et al. The potential role of ER beta isoforms in the clinical management of breast cancer [J]. Histopathology, 2008; 53(4): 374380.
|
7. |
Lazennec G. Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis [J]. Cancer Lett, 2006; 231(2): 151157.
|
8. |
Chen L, Qiu J, Yang X, et al. Identification of a novel estrogen receptor beta1 binding partner, inhibitor of differentiation1, and role of ERbeta1 in human breast cancer cells [J]. Cancer Lett, 2009; 278(2): 210219.
|
9. |
Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta [J]. Mol Interv, 2003; 3(5): 281292.
|
10. |
Cheskis BJ, Greger JG, Nagpal S, et al. Signaling by estrogens [J]. J Cell Physiol, 2007; 213(3): 610617.
|
11. |
Ji Q, Liu PI, Elshimali Y, et al. Frequent loss of estrogen and progesterone receptors in human prostatic tmmors determined by quantitative realtime PCR [J]. Mol Cell Endocrinol, 2005; 229(12): 103110.
|
12. |
Hartman J, Lindberg K, Morani A, et al. Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts [J]. Cancer Res, 2006; 66(23): 1120711213.
|
13. |
Hartman J, Strm A, Gustafsson JA. Estrogen receptor beta in breast cancer-diagnostic and therapeutic implications [J]. Steroids, 2009; 74(8): 635641.
|
14. |
Gustafsson JA, Warner M. Estrogen receptor beta in the breast: role in estrogen responsiveness and development of breast cancer [J]. J Steroid Biochem Mol Biol, 2000; 74(5): 245248.
|
15. |
Fox EM, Davis RJ, Shupnik MA. ERbeta in breast canceronlooker, passive player, or active protector [J]. Steroids, 2008; 73(11): 10391051.
|
16. |
Lane DP, Crawford LV. T antigen is bound to a host protein in SV40transformed cells [J]. Nature, 1979; 278(5701): 261263.
|
17. |
Meek DW. Tumour suppression by p53: a role for the DNA damage response [J]. Nat Rev Cancer, 2009; 9(10): 714723.
|
18. |
Efeyan A, Serrano M. p53: guardian of the genome and policeman of the oncogenes [J]. Cell Cycle, 2007; 6(9): 10061010.
|
19. |
Gavrieli Y, Sherman B, BenSasson SA, et al. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation [J]. J Cell Biol, 1992; 119(3): 493501.
|
20. |
Nayak SK, Panesar PS, Kumar H. p53induced apoptosis and inhibitors of p53 [J]. Curr Med Chem, 2009; 16(21): 26272640.
|
21. |
孙治君, 周鑫, 姚榛祥, 等. Pgp、nm23 和p53 联合检测判断乳腺癌预后的价值 [J]. 中国普外基础与临床杂志, 2005; 12(3): 244248.
|
22. |
Bedi A, Mookerjee B. Biological significance and molecular mechanisms of P53induced apoptosis [J]. Apoptosis, 1998; 3(4): 237244.
|
23. |
Amaral JD, Castro RE, Solá S, et al. p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis [J]. J Biol Chem, 2007; 282(47): 3425034259.
|
24. |
Hainaut P, Wiman KG. 30 years and a long way into p53 research [J]. Lancet Oncol, 2009; 10(9): 913919.
|
25. |
于冰, 孙治君. 凋亡相关基因bcl2、bax、bad与乳腺癌 [J]. 中国普外基础与临床杂志, 2007; 14(6): 739742.
|